Quick Takeaways
- Orca Capital AG filed SCHEDULE 13G for Co-Diagnostics, Inc. Common Stock, par value $0.001 per share (CODX).
- Disclosed ownership: 9.9%.
- Date of event: 17 Sep 2025.
Orca Capital AG - 17 Sep 2025 SCHEDULE 13G Report for Co-Diagnostics, Inc. Common Stock, par value $0.001 per share (CODX)
- Filing Manager
- Orca Capital AG
- Reporting Manager
- Orca Capital AG
- Symbol
- CODX
- Shares outstanding
- 48,580,808 shares
- Disclosed Ownership
- 4,809,500 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 18 Sep 2025, 16:05:12 UTC
- Date of event
- 17 Sep 2025
- Next filing
- 19 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Orca Capital AG disclosed 9.9% ownership in Co-Diagnostics, Inc. Common Stock, par value $0.001 per share (CODX) on 17 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Sep 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Orca Capital AG | 9.9% | 4,809,500 | 4,809,500 | 0 | /s/ Thomas Konig | Thomas Konig/Director |